Chairman and CEO of Global Med Technologies, Inc. to be Interviewed by Leading Audio Web Cast.

Business/Technology Editors

LAKEWOOD, Colo--(BUSINESS WIRE)--Aug. 18, 2000

-- to Discuss Historic Contract With Pacificare of Colorado for

Disease Management Software

Michael I. Ruxin, M.D., Chairman and CEO of Denver, CO based Global Med Technologies, Inc. (OTCBB:GLOB), will be interviewed today at 6:30 pm EST, on CEO Cast (www.ceocast.com) - a renowned audio web cast that is listened to by many leading Wall Street executives. During the fifteen-minute interview, Dr. Ruxin will talk about his company's five-year, $2.8-million contract with PacifiCare of Colorado for the revolutionary disease management software called DyniSoft(TM), that was developed by Global Med's subsidiary, PeopleMed.com, Inc.

In addition to describing the significance of Global Med's contract with PacifiCare of Colorado, Dr. Ruxin is also expected to discuss:

--How DyniSoft is expected to help the HMO industry and its clients;

--What this contract means for the future of the e-Health industry;

--Global Med's other revolutionary software system - SafeTrace Tx.com;

--The potential impact of SafeTrace Tx.com in addressing the nation's blood shortage;

--What makes Global Med Technologies unique and why the company is regarded as a leader in the medical technology field;

--The future of medical technology and other technological developments that Global Med Technologies is working on in the United States and Asia; and

--Upcoming products.

Global Med Technologies, Inc. is an e-Health medical information technology company that provides information management software products and services to the healthcare industry. Global Med's division, Wyndgate Technologies, is a leading supplier of management information systems to U.S. blood centers. Recently, Wyndgate Technologies developed SafeTrace Tx(TM).com, a new, Internet software system designed to meet the current and projected needs of hospital blood transfusion services. SafeTrace Tx.com offers a flexible, full-function application to integrate with the SafeTrace(R) donor center information system. SafeTrace is currently used to manage more than 20% of the nation's blood supply.

For more information about Global Med Technologies, Inc.'s products, please check its web site at www.globalmedtech.com or www.peoplemed.com or call Tom Marcinek, President and COO, at [phone].

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this document.